Welcome to the 15th IHEM 2022
H. Gisslinger
AOP Health welcome
G. Fischer
Role of inflammation in MPN
A. Fleischman
Clonal evolution of MPN
R. Skoda
COFFEE BREAK
Unmet need in ET
A. Alvarez - Larrán
How I treat ET
R. Kušec
Patient case IFN in ET
M. Krauth
EARLY INTERVENTION IN PV - AIMING FOR DISEASE MODIFICATION
CHAIRS: J.J Kiladjian & H. Gisslinger
Pre-clinical aspects
A. Mullally
IFN guidelines
T. Barbui
Practical considerations
M. Griesshammer
LUNCH BREAK
Ropeg for low risk PV - Academic question or reality?
P. Schafhausen
Pre-treated PV
S. Papageorgiou
CHIP patient
M. Egyed
Switch patient case
T. Sliwa
Combination therapy
H. Gisslinger
Efficacy of interferon in PV - A matter of dose?
J. Göthert
COFFEE BREAK
TKIs - A backbone with limitations
F. Stegelmann
IFN in CML - a critical review
A. Burchert
Pre- PMF - Where are we heading to?
H. Gisslinger
Pre- PMF patient cases
V. Buxhofer-Ausch
MF - How I treat
F. Passamonti
Secondary AML
D. Wolf
New compounds
J.J Kiladjian
